Business Context and Reporting Period
This Form 8-K filing by Chardan NexTech Acquisition 2 Corp. (a Special Purpose Acquisition Company, or SPAC) covers events occurring between August 13, 2021, and August 18, 2021. The filing details the consummation of the Company's Initial Public Offering (IPO), the exercise of the underwriters' over-allotment option, and related private placements of warrants.
Key Financial Metrics
- IPO Gross Proceeds: $110,000,000 from the sale of 11,000,000 Units at $10.00 per Unit.
- Over-Allotment Proceeds: $16,500,000 from the sale of 1,650,000 additional Units at $10.00 per Unit.
- Private Placement Proceeds: $4,052,000 from the initial sale of 4,361,456 Private Warrants at $0.93 per warrant.
- Additional Private Placement Proceeds: $247,500 from the sale of 266,402 Additional Private Warrants at $0.93 per warrant.
- Total Trust Account Balance (as of Aug 18, 2021): $128,397,500.
- Debt and Liquidity: The filing does not disclose specific debt obligations or operating cash flow metrics, as the entity is a pre-business combination SPAC. Liquidity is primarily represented by the Trust Account balance.
Material Changes
The primary material change is the transition from a private entity to a public company with significant capital raised. The Company completed its IPO on August 13, 2021, and subsequently closed the over-allotment option on August 18, 2021. These transactions resulted in the deposit of $128,397,500 into the Trust Account, which is restricted until the completion of an initial business combination or a redemption event.
Outlook, Risks, and Contingencies
- Business Combination Timeline: The Company must complete an initial business combination within 12 months (extendable to 18 months) from the IPO closing date.
- Trust Account Restrictions: Funds in the Trust Account generally cannot be released until the business combination is completed or a redemption occurs. Exceptions exist for taxes and up to $100,000 for dissolution expenses.
- Redemption Rights: Public stockholders have the right to redeem their shares prior to a voluntary winding-up if the Company fails to consummate a business combination within the applicable period.
- Emerging Growth Company: The registrant has elected to be treated as an emerging growth company.
Investor Verification Checklist
- Verify the final audited balance sheet (Exhibit 99.1) to confirm the exact cash position and any underwriting fees or deferred costs not explicitly detailed in the summary text.
- Review the terms of the Private Warrants and Additional Private Warrants to understand exercise prices and potential dilution.
- Confirm the specific deadline for the initial business combination (12 vs. 18 months) based on the definitive IPO prospectus.
- Check for any subsequent filings regarding the selection of a target company for the business combination.